2/9/2009

GlaxoSmithKline is reportedly negotiating to take over Piramal Healthcare, a generic-drug firm in India, for about $1.5 billion. The talks are preliminary and could be terminated, sources said. Piramal said the report is "totally unfounded."

Related Summaries